People

Kelsey Repka Managing Associate

New York

Kelsey, based in the New York Office, works closely with innovative startups and venture capital investors, helping them navigate the legal complexities of growing their business. Focusing on venture capital financings, mergers and acquisitions, and corporate governance, Kelsey enjoys guiding clients from the early stages of their journey through to successful exits.

Lindsay Rindskopf Senior Associate

New York

Lindsay has experience with trade dress and trademark litigation in federal district courts, trademark proceedings before the International Trade Commission, and cancellation and opposition proceedings before the Trademark Trial and Appeal Board. She also has extensive experience with copyright litigation before the federal district courts, trademark prosecution and clearance, domain name monitoring, and Uniform Domain-Name Dispute Resolution Policy (UDRP) matters.

Prior to joining Orrick, Lindsay attended Columbia Law School where she participated as a student editor for the Columbia Journal of Law & the Arts.

 

Jonas Robison Of Counsel

New York

He regularly advises on bank regulations (including, but not limited to, the Bank Holding Company Act and Regulation Y; the Federal Reserve Act; OCC regulations; Regulations U, X, and T; Regulation W; Regulation K; New York Banking Law; and U.S. regulation of foreign banks); CFTC and derivatives regulatory matters (including uncleared swap margin and capital rules, commodity pool operator and commodity trading advisor requirements, product and registrant definitions, the application of CFTC requirements to digital assets, the cross-border framework, swap data reporting, business conduct rules, mandatory clearing and related exceptions, and various key issues for derivatives end users); broker-dealer regulation; regulation of fintech companies, including digital asset clients, robo-advisers, and nonbank lenders; the Investment Advisers Act; the Investment Company Act; and the securities laws generally.

He also regularly negotiates equity and other types of derivatives transactions and related derivatives documentation on both the sell and the buy sides. In addition, he represents issuers and underwriters in commercial mortgage, auto loan, credit card, and other types of securitizations. He also has a broad background in mergers and acquisitions, capital markets, venture capital, corporate governance, and general corporate matters.

Kevin Roche Partner

New York

Kevin’s experience includes various general obligation and revenue bond financings, including those relating to transportation, multi-family housing, higher education, public power, sewer and water, and hospitals.

He has extensive knowledge and experience with federal securities laws issues in public finance, including both initial and continuing disclosure issues, material events disclosure, public statements liability, public offerings and private placements and other matters.

Kevin is a frequent speaker at conferences, seminars and webinars given by trade and professional organizations within the public finance industry.

Prior to entering private practice, Kevin was an Assistant Corporation Counsel in the Municipal Finance Division of the New York City Law Department.

Kaitlyn Rodnick Associate

New York

Kaitlyn is experienced in Hatch-Waxman litigation and inter partes review proceedings, including disputes involving drug treatments for cancer, therapeutic antibodies, and medical devices. Kaitlyn also has significant experience in IP due diligence and licensing associated with high-profile acquisitions.

Alison Roffi General Counsel

New York

Alison advises the firm on matters related to corporate governance, client relationships, and professional responsibility and ethics related to the practice of law. She has developed deep experience in the ethical considerations surrounding the use of legal tech, including AI and GenAI tools.

Alison provides legal advice to Orrick’s Board and Management Committee regarding firm management, growth, and policies. She is a member of the firm’s Operations Team and sits on the Risk Management Committee and AI Council. She also serves on the Risk Management Committee of MPC, the firm’s malpractice insurer.

Prior to joining the firm’s Office of General Counsel, Alison was a litigator in the firm’s Complex Litigation and Dispute Resolution group. Her practice focused on representing audit firms and accountants in regulatory proceedings as well as civil disputes related to professional liability and representing insurance policyholders in matters related to coverage, claims, and recovery. She has experience managing and conducting large-scale internal investigations, liaising with regulators, and managing cross-border risk and liability. Alison also defended financial institutions in lawsuits arising out of the global financial crisis.

Camille Joanne Rosca Partner

New York

Camille has represented public companies and other large national and multinational enterprises in financial services-related litigation, including Goldman Sachs, Credit Suisse, and Nationstar Mortgage LLC d/b/a Mr. Cooper, in federal and state court proceedings across the country. She has extensive experience defending clients in litigation alleging fraud, breach of contract, tort claims, class action claims, and securities law violations, including:

• Defending sponsors and underwriters of residential mortgage-backed securities against breach of contract and securities fraud actions brought by institutional investors, securitization trustees, and regulators in federal and state courts across the United States.
• Defending one of the largest mortgage servicers in the country against complex breach of contract claims brought by an investment management firm.
• Defending and advising companies with class action lawsuits against consumer protection claims, including one of the world's largest investment management firms in connection with multiple consumer class action lawsuits across state and federal jurisdictions.
• Defending one of the largest private equity firms in the country against breach of contract and statutory claims.

Prior to joining Orrick, Camille served as a law clerk to Justice Anne M. Patterson of the New Jersey Supreme Court. With her New Jersey connections, Camille has remained active in the New Jersey bar, advising and acting as local counsel in a number of pending complex litigation matters in New Jersey state and federal courts.

Camille is active in pro bono matters, including representing veterans.  She has represented clients in partnership with the National Veterans Legal Services Program and Veterans Advocacy Project. 

Camille is also one of the co-chairs of the Financial Services Network for the National Asian Pacific American Bar Association and co-leads Orrick’s DiversAbility Network.

B. J. Rosen Partner

New York

B. J. is also the Senior Outside Legal Advisor to The Innocence Project, an organization dedicated to exonerating wrongly-convicted prisoners through DNA testing and reforming the criminal justice system to prevent future injustice.

Jill Rosenberg Partner

New York

She handles complex individual cases, as well as class actions and systemic government investigations. She represents a broad range of companies, including employers in the securities industry, banks and financial institutions, accounting firms, law firms, and employers in the technology and media industries. Jill also has particular proficiency in the representation of nonprofit entities, including colleges, universities, hospitals, foundations and cultural institutions.

She designs and conducts training programs for clients and frequently speaks on employment law issues for employer and bar association groups such as National Employment Law Institute, Practising Law Institute, National Association of College and University Attorneys and the New York State Bar Association.

E. Joshua Rosenkranz Partner

New York

Josh has been named American Lawyer's “Litigator of the Year” twice, in addition to being a finalist for 2022. In 2012, the magazine dubbed him “the Defibrillator” based on his streak of appellate wins for companies that “appeared to be at death’s door,” and in 2017 it declared, he “still deserves the moniker we once gave him.”

In 2014, The Financial Times named Josh one of the 10 most innovative lawyers in the North American legal sector for his work “demystify[ing] the technical issues” and securing a victory in the blockbuster Federal Circuit appeal, Oracle v. Google. Chambers USA has reported, “He wins accolades for his ‘brilliant analysis and judgment.’ Clients appreciate how he ‘rethinks every case from the ground up,’ and add: ‘He can take the most complicated legal or technological issue and present it in a way that seems like common sense.’” Another edition of Chambers USA added: “‘His briefs are quite simply beautiful,’” and “clients describe his courtroom presence as ‘both commanding and accessible at the same time.’ He has the ‘perfect combination of persuasiveness, intelligence, wit, and deference.’”

Josh's practice covers a wide range of subjects, including intellectual property, financial services, securities, privacy, antitrust, federal preemption, insurance law, corporate governance, criminal law, and constitutional litigation. Among his recent clients are Cisco, Credit Suisse, Cox Communications, DISH Network, Genentech, Gilead, Johnson & Johnson, JPMorgan Chase, Microsoft, Mozilla, Oracle, Sonos, and Royal Bank of Scotland.

Clients turn to Josh to win the highest stakes appeals, including appeals in cases that threaten the very survival of a business. For example:

• He represented Microsoft in an international cause célèbre in the U.S. Supreme Court challenging the U.S. Government’s claim that it can serve warrants for emails stored overseas.
• He represented DISH Network in one of the most high-profile patent appeals in the country, successfully overturning an injunction that threatened the company's life.
• He has been lead counsel in multiple cases either defending or challenging verdicts over $1 billion.
• He represented Facebook in the high-profile battle waged by the founder's Harvard classmates, the Winklevoss twins, who laid claim to the idea for Facebook, winning a ruling from the Ninth Circuit to end the lawsuit.
• He won a landmark victory in a Supreme Court case that rescued the estimated $60 billion U.S. market of copyrighted goods manufactured abroad.
• He represented 36 law schools in a high-profile Supreme Court case against the Department of Defense.

Josh was the founding president and CEO of the Brennan Center for Justice at New York University School of Law, one of the country’s foremost public interest firms. Over the course of eight years, he was the Brennan Center’s chief strategist on litigation and public policy advocacy. Before that, Josh founded the Office of the Appellate Defender, a public defender office specializing in criminal appeals.

Ari Roytenberg Senior Associate

New York

Ari's experience includes supervising cases through all phases of litigation, from pre-litigation strategy through appeal. Most recently, Ari served as lead counsel to an aerospace defense company in litigation that began in New York State court and continued through a six-month trial in bankruptcy court in connection with a $1.3 billion restructuring transaction. His courtroom advocacy, briefing strategies, and fact and expert depositions have helped secure favorable outcomes to a number of clients involved in high-stakes disputes.

Before joining Orrick, Ari was an associate with Quinn Emanuel Urquhart & Sullivan LLP and served as a law clerk to Judge Richard M. Berman on the United States District Court for the Southern District of New York.

Irena Royzman, Ph.D. Partner

New York

With a Ph.D. in biology from MIT and the Whitehead Institute, where she was a NSF fellow, Irena represents plaintiffs and defendants in their most complex pharmaceutical and biotech patent cases. Over the last 20 years, pharmaceutical and biotechnology innovators have relied on Irena again and again for cases involving small molecules, biologics, recombinant DNA technology, gene therapy, gene editing, manufacturing processes, formulations and drug-eluting medical devices, including numerous multi-billion dollar cases involving many of the world’s best-selling drugs.

Irena has significant experience in litigation under the Hatch-Waxman Act and the Biologics Price Competition and Innovation Act (BPCIA), as well as inter partes review (IPR) proceedings, license disputes and matters with parallel ex-U.S. litigation and proceedings in foreign patent offices. Irena also helps life sciences companies and organizations develop the law in the most important cases for the biopharma industry. She has been principal counsel on numerous amicus briefs to the United States Supreme Court and the Federal Circuit in key biopharma cases.

For plaintiffs, Irena has successfully defended generic challenges to patents protecting blockbuster medical therapies, including multi-billion dollar cancer, antiviral and anti-psychotic drugs. She has also represented an innovator in some of the first cases under the BPCIA, including the first involving an antibody. For defendants, she defeated a $530 million claim of patent infringement of a competitor’s biotech patent, obtaining dismissal of all claims and discovery sanctions against the patent owner. In another high-stakes case, she obtained summary judgment of noninfringement and exclusion of plaintiff’s experts under Daubert as well as a full award of attorneys’ fees.

A registered patent attorney, Irena also handles inter partes review (IPR) proceedings. For patent owners, she has obtained denial of IPR for patents protecting blockbuster drugs and has leveraged IPR for defendants to obtain freedom to operate.

Irena also coordinates U.S. proceedings with parallel ex-U.S. litigation and proceedings in foreign patent offices, recently obtaining freedom to operate for a biotech innovator’s gene therapy. She provides strategic counseling in biologics and pharmaceuticals and advises clients on their IP portfolios and transactions. Irena also represents clients in high-stakes license disputes involving biotech patents, and, in a dispute concerning the use of a recombinant protein as an enzyme replacement therapy, obtained one of the largest settlement awards over the life of the contract.

Chambers USA has recognized Irena as a leading lawyer in intellectual property, where clients have described her as “excellent,” “knowledgeable, aggressive” and “an incredibly smart lawyer.” Benchmark Litigation named her one of the “Top 250 Women in Litigation” for the last seven years and a litigation star in intellectual property in New York. Irena was also named to the Crain’s New York Business 2021 list of Notable Women in Law.

Irena writes and lectures widely on biopharma patent issues and biosimilar litigation.  Irena also is frequently quoted on patent-related issues, including in the Washington Post, Financial Times, Nature Biotechnology and Pink Sheet.